Background Dry eye syndrome with tear deficiency can be improved with artificial tears,
which can be associated with topical anti-inflammatory agents. Autologous serum can …

Application of autologous serum to treat a multitude of ocular surface diseases and
conditions is a relatively new technique that has gained popularity over the past 10 years …

Eye drops made from autologous serum have been increasingly used in the past decade to
treat ocular surface disorders such as persistent epithelial defects and dry eye. Due to …

IN THIS ISSUE, SCHULZE AND ASSOCIATES REPORT THE results of a randomized
double-masked clinical trial comparing topical autologous serum with hyaluronic acid (HA) …

Purpose: To investigate therapeutic ocular surface medium (TOSM), a potential
physiological tear replacement therapy, for moderate to severe dry eye. Methods: Forty-six …

Purpose. To determine the efficacy and safety of topical autologous serum as a treatment of
dry eye patients. Methods. A 2-month, prospective, single-masked, placebo-controlled study …

Purpose To evaluate the efficacy and safety of allogeneic serum in the treatment of
persistent corneal epithelial defect (PED). Methods Thirty-six patients with PED whose …

The article discusses the retrospective crossover study on the use of serum eye drops (SED)
to manage ocular surface disease. Topics mentioned include the switch of several …

The majority of patients with dry eye syndromes respond to conventional treatment aimed at
optimising the ocular surface environment. There are some, however, who do not respond …

Abstract Purpose of Review In this article, we review the latest clinical outcomes of the
treatment of ocular surface diseases with autologous blood products. Recent Findings …